Danaher Earned $2.39 per Share for Q3

This morning, Danaher (DHR) reported Q3 earnings of $2.39 per share. That’s up 39% from a year ago. Wall Street had been expecting earnings of $2.15 per share.

Quarterly revenues grew by 20.5%. Danaher had been expecting revenue growth in “the mid- to high-teens percent range.”

Rainer M. Blair, President and Chief Executive Officer, stated, “Our team delivered another outstanding result in the third quarter, with over 20% core revenue growth and terrific earnings and cash flow performance. We continued to invest for growth across our businesses, expanding production capacity and accelerating innovation initiatives. Additionally, the recently closed acquisition of Aldevron enhances our portfolio and expands our capabilities into the important field of genomic medicine.”

Blair continued, “Our performance is a testament to the power of our portfolio and our team’s commitment to the Danaher Business System, and we see significant opportunities ahead to continue building sustainable, long-term value for shareholders.”

Now for guidance. For Q4, Danaher expects revenue growth “in the low-to-mid teens percent range.” For all of 2021, Danaher sees revenue growth in excess of 20%. That’s an increase over the previous guidance of “approximately 20%.”

We also learned that jobless claims came in at 290,000. That’s down 6,000 and it’s another post-pandemic low. Continuing claims fell 122,000 to 2,481,000.

Posted by on October 21st, 2021 at 8:32 am


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.